Academic and noncommercial basic research has always been an engine for innovation, particularly in the areas of medicine and drugs.
Technology: Abbott’s $1.6 billion global settlement illustrates government’s commitment to health care fraud enforcement
Last month, the government obtained one of the largest settlements ever in a health care fraud matter, as Abbott Laboratories agreed to pay $1.6 billion to settle allegations that it unlawfully marketed its drug, Depakote.
In my previous article, we discussed the balances presently being made in the implementation of the American Invents Act (AIA). As stated in that article, the nature of the bargain struck often depends on your perspective.